Shares of American Express fell after its second-quarter revenue narrowly missed analyst expectations and operating expenses climbed, overshadowing a solid earnings beat and strong consumer spending data.
Sanofi has ceased all clinical development of amlitelimab for atopic dermatitis, a key pipeline asset, citing an unfavorable risk-benefit profile. The decision has intensified investor concerns about the company's future growth beyond its blockbuster drug Dupixent.
Shares of the pump manufacturer gained after its Q2 2026 report showed a beat on earnings per share and a significant expansion in operating margins, overshadowing a slight shortfall in revenue.
Commerzbank Chairman Jens Weidmann has invited UniCredit to open merger talks, signaling a shift from resistance to negotiation after the Italian bank amassed a nearly controlling 48% stake. The German lender is now focused on securing concessions for its staff, shareholders, and customers.
Meta is introducing a new, no-cost verification system that uses a video selfie to confirm a user is a real person, a move aimed at enhancing trust and safety on its platform.
Major investment banks including Jefferies, BofA, and Baird have significantly increased their price targets for AMD, citing the launch of its Helios AI system, key customer wins like Anthropic, and a sharply higher long-term market forecast.
Barclays strategists say upcoming Big Tech earnings and central bank decisions will define the summer market outlook, warning that rising oil prices and bond yields are tilting risks to the downside despite strong corporate results.
Sensient Technologies (SXT) shares surged after the company posted second-quarter results that surpassed analyst estimates and significantly raised its full-year earnings guidance, citing strong demand for natural colors.
Investors withdrew a net $7.34 billion from U.S. equity funds in the week ending July 22, according to LSEG Lipper data, as disappointing results from some tech giants fueled caution.
